Plain-English translation of NCT06767501 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called E-GRAFT™, which is a dehydrated tissue patch made from amniotic membrane (the inner lining of the placenta), to see if it helps diabetic foot wounds heal better than standard care alone. Half of the participants will receive this tissue patch as their primary wound dressing, while the other half will receive a standard collagen-based dressing. Both groups will also receive all the usual wound care treatments for diabetic foot ulcers.
Diabetic foot ulcers are serious wounds that don't always heal well with standard care alone, and some patients face the risk of amputation. Researchers want to know whether this tissue-based treatment can help more wounds close completely and heal faster than current standard dressings.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the tissue patch (E-GRAFT™) or the standard collagen dressing as your primary wound covering. You will continue to receive all standard wound care, including regular cleaning and offloading (pressure relief) of your foot. You will need to attend weekly study visits for the researchers to examine your wound and measure its progress. The study will track whether your wound heals completely over the course of 12 weeks and beyond.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States